Excision Repair Cross Complementation Group 1 Single Nucleotide Polymorphisms and Nivolumab in Advanced Non-Small Cell Lung Cancer

Background: We hypothesized that non-small cell lung cancer (NSCLC) patients with a tumor positive for single nucleotide polymorphisms (SNPs) of the Excision Repair Cross Complementation Group 1 (ERCC-1) gene could be more genetically instable and consequently more responsive to a programmed cell de...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Oncol
Hlavní autoři: Aiello, Marco Maria, Solinas, Cinzia, Santoni, Matteo, Battelli, Nicola, Restuccia, Nunzio, Latteri, Fiorenza, Paratore, Sabrina, Verderame, Francesco, Albanese, Giuseppina Valeria, Bruzzi, Paolo, Soto Parra, Hector Josè
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2020
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7493643/
https://ncbi.nlm.nih.gov/pubmed/32983959
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.01167
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky